Accès gratuit
Numéro
Med Sci (Paris)
Volume 23, Numéro 5, Mai 2007
Page(s) 515 - 518
Section M/S revues
DOI https://doi.org/10.1051/medsci/2007235515
Publié en ligne 15 mai 2007
  1. Ohta T, Elnemr A, Yamamoto M, et al. Thiazolidinedione, a peroxisome proliferator-activated receptor-gamma ligand, modulates the E-cadherin/beta-catenin system in a human pancreatic cancer cell line, BxPC-3. Int J Oncol 2002; 21 : 37–42. [Google Scholar]
  2. Lampen A, Grimaldi PA, Nau H. Modulation of peroxisome proliferator-activated receptor delta activity affects neural cell adhesion molecule and polysialyltransferase ST8SiaIV induction by teratogenic valproic acid analogs in F9 cell differentiation. Mol Pharmacol 2005; 68 : 193–203. [Google Scholar]
  3. Collet P, Domenjoud L, Devignes MD, et al. The human semaphorin 6B is down regulated by PPARs. Genomics 2004; 83 : 1141–50. [Google Scholar]
  4. Bloch-Gallego E, Sotelo C. Chimio-attraction ou chimio-répulsion axonale : rôle des nétrines et des sémaphorines. Med Sci (Paris) 1998; 14 : 44–52. [Google Scholar]
  5. Murad H, Collet P, Huin-Schohn C, et al. Effects of PPAR and RXR ligands in semaphorin 6B gene expression of human MCF-7 breast cancer cells. Int J Oncol 2006; 28 : 977–84. [Google Scholar]
  6. Wang N, Verna L, Chen NG, et al. Constitutive activation of peroxisome proliferator-activated receptor-γ suppresses pro-inflammatory adhesion molecules in human vascular endothelial cells. J Biol Chem 2002; 277 : 34176–81. [Google Scholar]
  7. Jackson SM, Parhami F, Xi XP, et al. Peroxisome proliferator-activated receptor activators target human endothelial cells to inhibit leukocyte-endothelial cell interaction. Arterioscl Thromb Vasc 1999; 19 : 2094–104. [Google Scholar]
  8. Imamoto E, Yoshida N, Uchiyama K, et al. Inhibitory effect of pioglitazone on expression of adhesion molecules on neutrophils and endothelial cells. Biofactors 2004; 20 : 37–47. [Google Scholar]
  9. Sasaki M, Jordan P, Welbourne T, et al. Troglitazone, a PPAR-γ activator prevents endothelial cell adhesion molecule expression and lymphocyte adhesion mediated par TNF-α BMC Physiol 2005; 5 : 3. [Google Scholar]
  10. Kurebayashi S, Xu X, Ishii S, et al. A novel thiazolidinedione MCC-555 down-regulates tumor necrosis factor-α-induced expression of vascular cell adhesion molecule-1 in vascular endothelial cells. Atherosclerosis 2005; 182 : 71–7. [Google Scholar]
  11. Lieu D, Zeng BX, Zhang SH, et al. Rosiglitazone, an agonist of peroxisome proliferator-activated receptor γ, reduces pulmonary inflammatory response in a rat model of endotoxemia. Inflamm Res 2005; 54 : 464–70. [Google Scholar]
  12. Besson VC, Chen XR, Plotkine M, et al. Fenofibrate, a peroxisome proliferator-activated receptor α agonist, exerts neuroprotective effects in traumatic brain injury. Neurosci Lett 2005; 388 : 7–12. [Google Scholar]
  13. Vlaeminck-Guillem V, Laudet V, Duterque-Coquillaud M. Negative cross-talk between nuclear receptors and transcription factors: implications in inflammation and oncogenesis. Med Sci (Paris) 2003; 19 : 1121–7. [Google Scholar]
  14. Hazra S, Miyahara T, Rippe RA, et al. PPAR gamma and hepatic stellate cells. Comp Hepatol 2004; 3 : 57–9. [Google Scholar]
  15. Yavrom S, Chen L, Xiong S, et al. Peroxisome proliferator-activated receptor γ suppresses proximal α1(I) collagen promoter via inhibition of p300-facilitated NF-I binding to DNA in hepatic stellate cells. J Biol Chem 2005; 280 : 40650–9. [Google Scholar]
  16. Masamune A, Kikuta K, Satoh M, et al. Ligands of peroxisome proliferator-activated receptor γ block activation of pancreatic stellate cells. J Biol Chem 2002; 277 : 141–7. [Google Scholar]
  17. Van Westerloo DJ, Florquin S, de Boer AM, et al. Therapeutic effects of troglitazone in experimental chronic pancreatitis in mice. Am J Pathol 2005; 166 : 721–8. [Google Scholar]
  18. Burgess HA, Daugherty LE, Thatcher TH, et al. PPARγ agonists inhibit TGF-β induced pulmonary myofibroblast differentiation and collagen production : implications for therapy of lung fibrosis. Am J Physiol Lung Cell Mol Physiol 2005; 288 : L1146–53. [Google Scholar]
  19. Zafiriou S, Stanners SR, Saad S, et al. Pioglitazone inhibits cell growth and reduces matrix production in human kidney fibroblasts. J Am Soc Nephrol 2005; 16 : 638–45. [Google Scholar]
  20. Chen K, Chen J, Li D, et al. Angiotensin II regulation of collagen type I expression in cardiac fibroblasts. Modulation by PPAR-γ ligand pioglitazone. Hypertension 2004; 44 : 655–61. [Google Scholar]
  21. Guo B, Koya D, Isono M, et al. Peroxisome proliferator-activated receptor-γ ligands inhibit TGF-β1-induced fibronectin expression in glomerular mesangial cells. Diabetes 2004; 53 : 200–8. [Google Scholar]
  22. Maeda A, Horikoshi S, Godha T, et al. Pioglitazone attenuates TGF-β1-induction of fibronectin synthesis and its splicing variant in human mesangial cells via activation of peroxisome proliferator-activated receptor (PPAR)γ. Cell Biol Int 2005; 29 : 422–8. [Google Scholar]
  23. Panchapakesan U, Sumual C, Pollock CA, et al. PPARγ agonists exert antifibrotic effects in renal tubular cells exposed to high glucose. Am J Physiol Renal Physiol 2005; 289 : F1153–8. [Google Scholar]
  24. Han SW, Ritzenthaler JD, Rivera HN, et al. Peroxisome proliferator-activated receptor-γ ligands suppress fibronectin gene expression in human lung carcinoma cells: involvement of both CRE and Sp1. Am J Physiol Lung Cell Mol Physiol 2005; 289 : L419–28. [Google Scholar]
  25. Han S, Rivera HN, Roman J. Peroxisome proliferator-activated receptor-γ ligands inhibit α5 integrin gene transcription in non-small cell lung carcinoma cells. Am J Respir Cell Mol Biol 2005; 32 : 350–9. [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.